Xenogen Corporation
Alameda
About Xenogen Corporation
Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen's VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $114.6M
- Funding stage: M&A
- Last round: Debt Financing (Oct 2005)
- Ticker: nasdaq:XGEN
- Website: xenogen.com
- Phone: 800-762-4000
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/xenogen-corporation-907649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.